UK ‘Gamechanger’ for Heart Disease, J&J HIV Vaccine Fails, & Purdue Dissolves

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.